Summary
The relationship between urinary protein excretion and control of diabetes was evaluated in alloxan-diabetic dogs prospectively assigned to poor, moderate, or good glycaemic control. Protein excretion rate increased with the duration of insulin deficiency, and was significantly greater than normal in the poor control group by the fourth year of diabetes. Appreciable differences in the severity of the proteinuria were observed among animals of the poor and moderate glycaemic control groups; some of the animals excreted in excess of 500 mg protein/24 h while others excreted no more than normal throughout the 5 years of study. Differences in glycaemic control among these insulin-deficient animals seem not sufficient to account for the observed differences in protein excretion. Immunoassay for albumin indicated that the defect resulting in supranormal protein excretion was at least partly glomerular in origin. Good glycaemic control prevented the protein loss from exceeding normal. A potential role of hyperglycaemia in the development of proteinuria was examined in nondiabetic dogs made experimentally hyperglycaemic with galactose. Consumption of a 30% galactose diet for up to 5 years duration had little influence on protein excretion.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Viberti G, Keen H (1984) The patterns of proteinuria in diabetes mellitus. Relevance to pathogenesis and prevention of diabetic nephropathy. Diabetes 33: 686–692
Hostetter TH, Rennke HG, Brenner BM (1982) The case for intrarenal hypertension in the initialion and progression of diabetic and other glomerulopathies. Am J Med 72: 375–383
Parving H-H, Viberti GC, Keen H, Christiansen JS, Lassen NA (1983) Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 32: 943–949
Mauer SM, Steffes MW, Goetz FC, Sutherland DER, Brown DM (1983) Diabetic nephropathy. A perspective. Diabetes 32 [Suppl 2]: 52–55
Deckert T, Feldt-Rasmussen B, Mathiesen ER, Baker L (1984) Pathogenesis of incipient nephropathy: a hypothesis. Diabetic Nephropalhy 3: 83–88
Fletcher JA, Crockson RA, Mijovic C, Cooper EH, Bradwell AR, Barnet AH (1986) Low molecular weight proteinuria in insulin-dependent diabetes. Diabetes Res 3: 203–206
Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in Type I diabetes. Diabetologia 25: 496–501
Steffes MW, Mauer SM (1984) Diabetic glomerulopathy in man and experimental animal models. Int Rev Exp Pathol 26: 147–175
Bloodworth JMB Jr, Engerman RL (1971) Sponlaneous and induced diabetic microangiopathy. Acta Diabetol Lat 8 [Suppl 1]: 263–298
Brown DM, Andres GA, Hostetter TH, Mauer SM, Price R, Venkalachalam MA (1982) Kidney complications. Diabetes 31 [Suppl 1]: 71–81
Engerman R, Bloodworth JMB Jr, Nelson S (1977) Relationship of microvascular disease in diabetes to metabolic control. Diabetes 26: 760–769
Engerman RL, Kern TS (1984) Experimental galaclosemia produces diabetic-like retinopalhy. Diabetes 33: 98–100
Hawk PB, Oser BL, Summerson WH (1947) Practical physiological chemistry, 13th edn. Blakeston, New York, pp 929–930
Mancini G, Carbonara AO, Heremans JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2: 235–254
Johnson RN, Metcalf PA, Baker JR (1982) Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 127: 87–95
Bradford MM (1976) A rapid and sensitive melhod for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72: 248–254
Malone JI, Leavengood H, Peterson MJ, O'Brien MM, Page MG, Aldinger CE (1984) Red blood cell sorbitol as an indicator of polyol pathway activity: inhibition by sorbinil in insulin-dependent diabetic subjects. Diabetes 33: 45–49
Kern TS, Romang TC, Engerman RL (1986) Erythrocyte filterabilily in alloxan-diabetes and in experimental galactosemia. Clin Hemorheol 6: 395–404
Kern TS, Engerman RL (1987) Kidney morphology in experimental hyperglycemia. Diabetes 36: 244–249
Mogensen CE (1987) Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 31: 673–689
Rasch R (1980) Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment Albumin excretion. Diabetologia 18: 413–416
Rasch R (1979) Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Glomeralar basement membrane thickness. Diabetologia 16: 319–324
Rasch R (1979) Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment Mesangial volume. Diabetologia 17: 243–248
Rasch R (1979) Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Kidney size and glomerular volume. Diabetologia 16: 125–128
Kern TS, Engerman RL (1987) Effects of experimental hyperglycemia on kidney morphology. Diabetes 36 [Suppl 1]: 43A
Feldt-Rasmussen B, Mathiesen ER, Deckert T (1986) Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet II: 1300–1304
Bending JJ, Viberti GC, Bilous RW, Keen H, for the Kroc Collaborative Study Group (1985) Eight month correction of hyperglycemia in insulin-dependent diabetes mellitus is associated with a significant and sustained reduction of urinary albumin excretion rales in patients with microalbuminuria. Diabetes 34 [Suppl 3]: 69–73
Viberti GC, Bilous RW, Mackintoch B, Bending JJ, Keen H (1983) Long-term correction of hyperglycemia and progression of renal failure in insulin-dependent diabetes. Br Med J 286: 598–602
Tamborlane WV, Puklin JE, Bergman M, Verdonk C, Rudolf MC, Felig P, Genel M, Sherwin R (1982) Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. Diabetes Care 5 [Suppl 1]: 58–64
Zatz R, Meyer TV, Rennke HG, Brenner BM (1985) Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 82: 5963–5967
Beyer-Mears A, Cruz E, Edelisl T, Varagiannis E (1986) Diminished proteinuria in diabetes mellitus by Sorbinil, an aldose reductase inhibitor. Pharmacology 32: 52–60
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kern, T.S., Engerman, R.L. Urinary protein excretion rates in experimentally diabetic dogs and experimentally galactosaemic dogs. Diabetologia 31, 928–932 (1988). https://doi.org/10.1007/BF00265379
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00265379